Medisun Precision Medicine

Medisun Precision Medicine is a biotechnology company focused on regenerative medicine and precision diagnostics, primarily operating in Hong Kong and mainland China. The company specializes in the development and commercialization of stem cell-based therapies, including C-Cure, a cardiopoietic cell therapy designed to treat chronic heart failure. Beyond therapeutics, Medisun operates clinical centers providing comprehensive precision medicine services such as early cancer screening, genetic testing, and immune cell storage. The firm maintains strategic collaborations with international institutions like the Mayo Clinic to bring advanced medical technologies to the Asian market. Medisun's integrated business model bridges clinical research with personalized healthcare services to address life-threatening and chronic conditions.